Intech Biopharm Ltd (6461) — Working Capital to Net Assets Ratio
Intech Biopharm Ltd (6461) has a Working Capital to Net Assets ratio of 14.5% as of December 2025. Working capital of NT$159.81 Million (current assets of NT$403.13 Million minus current liabilities of NT$243.32 Million) is measured against net assets of NT$1.10 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Intech Biopharm Ltd (6461) financial flexibility to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Intech Biopharm Ltd Working Capital to Net Assets (2017–2025)
This chart shows how Intech Biopharm Ltd's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of December 2025, the ratio stands at 14.5%, reflecting working capital of NT$159.81 Million against net assets of NT$1.10 Billion TWD. See 6461 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Intech Biopharm Ltd (2017–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Intech Biopharm Ltd from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Intech Biopharm Ltd stock valuation.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 14.5% | NT$159.81 Million | NT$1.10 Billion | NT$403.13 Million | NT$243.32 Million | ▲ +11.6 pp |
| 2024 | 2.9% | NT$23.68 Million | NT$814.28 Million | NT$410.32 Million | NT$386.64 Million | ▼ -7.9 pp |
| 2023 | 10.8% | NT$126.30 Million | NT$1.17 Billion | NT$695.02 Million | NT$568.73 Million | ▲ +0.6 pp |
| 2022 | 10.2% | NT$105.24 Million | NT$1.03 Billion | NT$479.06 Million | NT$373.82 Million | ▲ +0.2 pp |
| 2021 | 10.0% | NT$133.11 Million | NT$1.34 Billion | NT$456.33 Million | NT$323.22 Million | ▼ -9.3 pp |
| 2020 | 19.2% | NT$255.25 Million | NT$1.33 Billion | NT$409.77 Million | NT$154.52 Million | ▲ +9.4 pp |
| 2019 | 9.8% | NT$153.23 Million | NT$1.57 Billion | NT$360.22 Million | NT$206.99 Million | ▲ +11.2 pp |
| 2018 | -1.4% | NT$-20.70 Million | NT$1.49 Billion | NT$231.12 Million | NT$251.81 Million | ▼ -0.3 pp |
| 2017 | -1.1% | NT$-14.78 Million | NT$1.36 Billion | NT$163.75 Million | NT$178.53 Million | — |